THMO

Thermogenesis Holdings Inc. (THMO) | Rumor.io

Thermogenesis Holdings

THMO

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)9.4M

Net income (annual)-18.9M

Social

What share of all stock conversation is about THMO?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Jun 12

ThermoGenesis Holdings, Inc. (THMO) received a delist determination from NASDAQ due to failure to meet the minimum shareholder equity requirement of $2.5M.
The company has until June 13 to appeal the delist determination, but currently does not intend to do so, which will result in the stock being transferred to the OTC market.
The stock's low float and low market cap make it a potential delist play, but investors should be aware of the limited time left before the delist date on June 17.

Generated by AI

Sentiment

Of the messages about THMO that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	100% +30.16
Bearish	—	—	—	0% -30.16

Bullish· Feb 16

$THMO has the potential to show double revenues this year with potential profits, and is waiting for 5 new FDA patents to be approved in 2025.
$THMO is expected to sign big agreements, with one potential deal worth up to $800 million in total, and is already showing strength with a 160% increase from $0.40 to $1.04.
$THMO's tight float could lead to explosive growth with increased volume, and it is already showing signs of a potential breakout with a bid getting higher while no shares are available to buy.

Bearish· Jun 6

$THMO has been in a strong downtrend, with a recent drop of 17.58% to $1.36 in the last 20 minutes.
The asset's price action is indicative of a failed short squeeze, with a dead cat bounce unable to occur due to the company's poor performance.
The stock is expected to continue falling, with some traders waiting for a final dip under $1 and others shorting the asset now that the "run is over".

Generated by AI

Topics

Of the messages about THMO that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	100%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	0%

Announcements· Mar 16

ThermoGenesis Holdings, Inc. (THMO) announced the rollout of ReadyStart CGMP suites for early-stage cell and gene therapy companies.
THMO entered into definitive agreements for the purchase and sale of 1,071,429 shares of its common stock and warrants to purchase 1,071,429 shares at $2.80 per share.
ThermoGenesis Holdings, Inc. (THMO) announced a $3 million private placement priced at-the-market under NASDAQ rules.

Technical Analysis· Mar 16

The 15-minute chart for $THMO shows previous resistance now as support, with the price waiting to reclaim $7.00.
A downtrend breakout in $THMO is expected, with the price potentially continuing higher after a correction.
The 1-hour chart for $THMO shows a beautiful pattern, but the author is cautious due to the bearish market, and is looking for shorts to exhaust before considering a buy.

Generated by AI

Community

Of the messages about THMO, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	11.76%
Newcomers	—	—	—	88.24%

Regulars· Jun 6

The stock price of THMO has risen 37% since the previous trading day's close, and it has also gained 11.21% in the pre-market, with a current price of $1.44.
The stock has seen significant trading volume, with the complete float of 1.3M shares being traded today, and a recent pop of 4.5% at 15:29.
The stock's recent price movement has been volatile, with a drop of 4.9% at 11:31 and a failed attempt at a dead cat bounce, with the stock currently trading at $1.17.

Newcomers· Mar 17

New traders are anticipating a "squeeze out" and expecting the price to return to lower levels after a recent surge, with some already taking profits.
There is unusual volume detected on the stock, with 479,512 shares traded in 5 minutes, and some traders are warning of a potential bull trap for new investors.
The company has announced a private placement of $3M, resulting in an 18% drop in the stock price, and some traders are taking note of this development.

Generated by AI

Also Discussed

Investors talking about THMO also mention

#	Name	Attention
1	Movella Holdings Inc.MVLA	0%0
2	PBLA - Panbela Therapeutics, Inc.	——
3	Star Equity Holdings Inc.STRR	0%0
4	Viveve Medical Inc.VIVE	0%0
5	WORX - SCWorx Corp.	——
6	GMO International Quality ETFQLTI	0%0
7	Schmitt Industries Inc.SMIT	0%new
8	Corgi All Commodities 2x Daily ETFXCOM	0%0
9	ARCK - Arbor Rapha Capital Bioholdings Corp. I	——
10	FATP - Fat Projects Acquisition Corp	——

Thermogenesis Holdings Inc.

Healthcare
Medical Devices

ThermoGenesis Holdings Inc. is a medical technology company specializing in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy industry. It offers a comprehensive suite of solutions tailored for automated clinical biobanking, point-of-care applications, and automation in immuno-oncology. A key product is the semi-automated CAR-Txpress platform, which streamlines the manufacturing process for CAR-T cell immunotherapy, supporting the growing demand in personalized medicine. These technologies enable efficient handling, preservation, and processing of cells critical for therapeutic applications, serving research institutions, biopharmaceutical companies, and clinical settings focused on regenerative medicine and cancer treatments. Founded in 1986 and headquartered in Rancho Cordova, California, ThermoGenesis Holdings Inc. plays a vital role in advancing accessible and scalable solutions within the rapidly evolving cell therapy sector.

Website

Location

2711 Citrus Road

Rancho Cordova, CA, 95742

United States

Social

What share of all stock conversation is about THMO?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Jun 12

ThermoGenesis Holdings, Inc. (THMO) received a delist determination from NASDAQ due to failure to meet the minimum shareholder equity requirement of $2.5M.
The company has until June 13 to appeal the delist determination, but currently does not intend to do so, which will result in the stock being transferred to the OTC market.
The stock's low float and low market cap make it a potential delist play, but investors should be aware of the limited time left before the delist date on June 17.

Generated by AI

Sentiment

Of the messages about THMO that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	100% +30.16
Bearish	—	—	—	0% -30.16

Bullish· Feb 16

$THMO has the potential to show double revenues this year with potential profits, and is waiting for 5 new FDA patents to be approved in 2025.
$THMO is expected to sign big agreements, with one potential deal worth up to $800 million in total, and is already showing strength with a 160% increase from $0.40 to $1.04.
$THMO's tight float could lead to explosive growth with increased volume, and it is already showing signs of a potential breakout with a bid getting higher while no shares are available to buy.

Bearish· Jun 6

$THMO has been in a strong downtrend, with a recent drop of 17.58% to $1.36 in the last 20 minutes.
The asset's price action is indicative of a failed short squeeze, with a dead cat bounce unable to occur due to the company's poor performance.
The stock is expected to continue falling, with some traders waiting for a final dip under $1 and others shorting the asset now that the "run is over".

Generated by AI

Topics

Of the messages about THMO that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	100%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	0%

Announcements· Mar 16

ThermoGenesis Holdings, Inc. (THMO) announced the rollout of ReadyStart CGMP suites for early-stage cell and gene therapy companies.
THMO entered into definitive agreements for the purchase and sale of 1,071,429 shares of its common stock and warrants to purchase 1,071,429 shares at $2.80 per share.
ThermoGenesis Holdings, Inc. (THMO) announced a $3 million private placement priced at-the-market under NASDAQ rules.

Technical Analysis· Mar 16

The 15-minute chart for $THMO shows previous resistance now as support, with the price waiting to reclaim $7.00.
A downtrend breakout in $THMO is expected, with the price potentially continuing higher after a correction.
The 1-hour chart for $THMO shows a beautiful pattern, but the author is cautious due to the bearish market, and is looking for shorts to exhaust before considering a buy.

Generated by AI

Community

Of the messages about THMO, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	11.76%
Newcomers	—	—	—	88.24%

Regulars· Jun 6

The stock price of THMO has risen 37% since the previous trading day's close, and it has also gained 11.21% in the pre-market, with a current price of $1.44.
The stock has seen significant trading volume, with the complete float of 1.3M shares being traded today, and a recent pop of 4.5% at 15:29.
The stock's recent price movement has been volatile, with a drop of 4.9% at 11:31 and a failed attempt at a dead cat bounce, with the stock currently trading at $1.17.

Newcomers· Mar 17

New traders are anticipating a "squeeze out" and expecting the price to return to lower levels after a recent surge, with some already taking profits.
There is unusual volume detected on the stock, with 479,512 shares traded in 5 minutes, and some traders are warning of a potential bull trap for new investors.
The company has announced a private placement of $3M, resulting in an 18% drop in the stock price, and some traders are taking note of this development.

Generated by AI

Thermogenesis Holdings

Social

Jun 12

Sentiment

Bullish· Feb 16

Bearish· Jun 6

Topics

Announcements· Mar 16

Technical Analysis· Mar 16

Community

Regulars· Jun 6

Newcomers· Mar 17

Also Discussed

Thermogenesis Holdings Inc.

Company Information

Location

Also Discussed

Social

Jun 12

Sentiment

Bullish· Feb 16

Bearish· Jun 6

Topics

Announcements· Mar 16

Technical Analysis· Mar 16

Community

Regulars· Jun 6

Newcomers· Mar 17